Your browser doesn't support javascript.
loading
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
Elez, Elena; Pericay, Carles; Valladares-Ayerbes, Manuel; Bando, Inmaculada; Safont, Maria Jose; Gallego, Javier; Grávalos, Cristina; Arrivi, Antonio; Carrato, Alfredo; Conde, Verónica; Ortiz, Maria José; López, Carlos; Alonso, Beatriz; Ruiz de Mena, Inmaculada; Díaz-Rubio, Eduardo; Tabernero, Josep; Aranda, Enrique.
Afiliação
  • Elez E; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Pericay C; Department of Medical Oncology, C.S. Parc Tauli, Barcelona, Spain.
  • Valladares-Ayerbes M; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
  • Bando I; IMIBIC, Reina Sofía Hospital, University of Córdoba, CIBERONC, Instituto de Salud Carlos III, Córdoba, Spain.
  • Safont MJ; Laboratory Hospital Clínico San Carlos. Instituto de Investigación Hospital Clínico San Carlos (IdISSC), University Complutense, Madrid, Spain.
  • Gallego J; CIBERONC, Madrid, Spain.
  • Grávalos C; Department of Medical Oncology, General Universitario de Valencia Hospital, Valencia, Spain.
  • Arrivi A; Department of Medical Oncology, General Universitario de Elche Hospital, Alicante, Spain.
  • Carrato A; Department of Medical Oncology, Universitario Doce de Octubre Hospital, Madrid, Spain.
  • Conde V; Department of Medical Oncology, Son Llàtzer Hospital, Palma de Mallorca, Spain.
  • Ortiz MJ; Clínica Rotger, Palma, Balearic Islands, Spain.
  • López C; Department of Medical Oncology, IRYCIS, CIBERONC, Alcalá University, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Alonso B; Department of Medical Oncology, Virgen de las Nieves Hospital, Granada, Spain.
  • Ruiz de Mena I; IMIBIC, Reina Sofía Hospital, University of Córdoba, CIBERONC, Instituto de Salud Carlos III, Córdoba, Spain.
  • Díaz-Rubio E; Department of Medical Oncology, Marqués de Valdecilla Hospital, Santander, Spain.
  • Tabernero J; Department of Medical Oncology, Universitario de Canarias Hospital, Tenerife, Spain.
  • Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), Madrid, Spain.
Br J Cancer ; 121(5): 378-383, 2019 08.
Article em En | MEDLINE | ID: mdl-31363167
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2019 Tipo de documento: Article